SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    John D. Merriman, Bradley E. Aouizerat, Janine K. Cataldo, Laura Dunn, Bruce A. Cooper, Claudia West, Steven M. Paul, Christina R. Baggott, Anand Dhruva, Kord Kober, Dale J. Langford, Heather Leutwyler, Christine S. Ritchie, Gary Abrams, Marylin Dodd, Charles Elboim, Deborah Hamolsky, Michelle Melisko, Christine Miaskowski, Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer, Cytokine, 2014, 65, 2, 192

    CrossRef

  2. You have free access to this content2
    Jamie Arndt, Enny Das, Sanne B. Schagen, Stephanie A. Reid-Arndt, Linda D. Cameron, Tim A. Ahles, Broadening the cancer and cognition landscape: the role of self-regulatory challenges, Psycho-Oncology, 2014, 23, 1
  3. 3
    Yin Ting Cheung, Yu Lee Foo, Maung Shwe, Yee Pin Tan, Gilbert Fan, Wei Sean Yong, Preetha Madhukumar, Wei Seong Ooi, Wen Yee Chay, Rebecca A. Dent, Soo Fan Ang, Soo Kien Lo, Yoon Sim Yap, Raymond Ng, Alexandre Chan, Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patients, Journal of Clinical Epidemiology, 2014, 67, 7, 811

    CrossRef

  4. 4
    Yin Ting Cheung, Maung Shwe, Earl Hsien Jie Tan, Wai Keung Chui, Raymond Ng, Alexandre Chan, Acknowledging the relevance of cognitive changes in cancer patients: perspectives of oncology practitioners in Asia, Journal of Cancer Survivorship, 2013, 7, 1, 146

    CrossRef

  5. 5
    Sanne B. Schagen, Jeffrey S. Wefel, Chemotherapy-related changes in cognitive functioning, European Journal of Cancer Supplements, 2013, 11, 2, 225

    CrossRef

  6. 6
    Brenna C. McDonald, Susan K. Conroy, Dori J. Smith, John D. West, Andrew J. Saykin, Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study, Brain, Behavior, and Immunity, 2013, 30, S117

    CrossRef

  7. 7
    Sara Monteiro, Ana Torres, Rita Morgadinho, Anabela Pereira, Psychosocial Outcomes in Young Adults with Cancer: Emotional Distress, Quality of Life and Personal Growth, Archives of Psychiatric Nursing, 2013, 27, 6, 299

    CrossRef

  8. 8
    Y. T. Cheung, M. Shwe, Y. P. Tan, G. Fan, R. Ng, A. Chan, Cognitive changes in multiethnic Asian breast cancer patients: a focus group study, Annals of Oncology, 2012, 23, 10, 2547

    CrossRef

  9. 9
    Lynn M. Breckenridge, Gina L. Bruns, Briana L. Todd, Michael Feuerstein, Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors, Psycho-Oncology, 2012, 21, 1
  10. 10
    Bok Yae Chung, Hye Sun Byun, Gyung Duck Kim, Kyung Hae Kim, Eun Hee Choi, Experiences of Changes in Cognitive Function for Women treated with Chemotherapy for Breast Cancer, Korean Journal of Women Health Nursing, 2012, 18, 1, 1

    CrossRef

  11. 11
    Bok Yae Chung, Hye Sun Byun, Gyung Duck Kim, Kyung Hae Kim, Eun Hee Choi, Experiences of Changes in Cognitive Function for Women treated with Chemotherapy for Breast Cancer, Korean Journal of Women Health Nursing, 2012, 18, 1, 1

    CrossRef

  12. 12
    Sanne B. Schagen, Enny Das, Ivar Vermeulen, Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients, Psycho-Oncology, 2012, 21, 10
  13. 13
    Yin Ting Cheung, Wai Keung Chui, Alexandre Chan, Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations, Critical Reviews in Oncology/Hematology, 2012, 83, 1, 99

    CrossRef

  14. 14
    C. M. T. Schilder, C. Seynaeve, S. C. Linn, W. Boogerd, L. V. A. M. Beex, C. M. Gundy, J. W. R. Nortier, C. J. H. van de Velde, F. S. A. M. van Dam, S. B. Schagen, Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study, Psycho-Oncology, 2012, 21, 5
  15. 15
    Stephanie A. Reid-Arndt, Cathy R. Cox, Stress, Coping and Cognitive Deficits in Women After Surgery for Breast Cancer, Journal of Clinical Psychology in Medical Settings, 2012, 19, 2, 127

    CrossRef

  16. 16
    K Ribi, J Aldridge, K-A Phillips, A Thompson, V Harvey, B Thürlimann, F Cardoso, O Pagani, A S Coates, A Goldhirsch, K N Price, R D Gelber, J Bernhard, Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer, British Journal of Cancer, 2012, 106, 10, 1618

    CrossRef

  17. 17
    T. MITCHELL, P. TURTON, ‘Chemobrain’: concentration and memory effects in people receiving chemotherapy – a descriptive phenomenological study, European Journal of Cancer Care, 2011, 20, 4
  18. 18
    Tone Skaali, Sophie D. Fosså, Alv A. Dahl, A Prospective Study of Cognitive Complaints in Patients With Testicular Cancer, Clinical Genitourinary Cancer, 2011, 9, 1, 6

    CrossRef

  19. 19
    Gyung Duck Kim, Bok Yae Chung, Kyung Hae Kim, Hye Sun Byun, Eun Hee Choi, Analysis of a Trend of Instrument Usage to Assess Cognitive Function of Breast Cancer Patients Undergoing Chemotherapy, Journal of Korean Oncology Nursing, 2011, 11, 3, 179

    CrossRef

  20. 20
    Fehmidah Munir, Katryna Kalawsky, Catherine Lawrence, Joanna Yarker, Cheryl Haslam, Samreen Ahmed, Cognitive Intervention for Breast Cancer Patients Undergoing Adjuvant Chemotherapy, Cancer Nursing, 2011, 34, 5, 385

    CrossRef

  21. 21
    Tone Skaali, Sophie D. Fosså, Stein Andersson, Milada Cvancarova, Carl W. Langberg, Gustav Lehne, Alv A. Dahl, Self-reported cognitive problems in testicular cancer patients: Relation to neuropsychological performance, fatigue, and psychological distress, Journal of Psychosomatic Research, 2011, 70, 5, 403

    CrossRef

  22. 22
    Robert Zachariae, Mimi Yung Mehlsen, Testicular cancer: Is chemotherapy associated with cognitive impairment?, Nature Reviews Urology, 2011, 8, 4, 182

    CrossRef

  23. 23
    Marleen J.J. Pullens, Jolanda De Vries, Jan A. Roukema, Subjective cognitive dysfunction in breast cancer patients: a systematic review, Psycho-Oncology, 2010, 19, 11
  24. You have free access to this content24
    Kerstin Hermelink, Helmut Küchenhoff, Michael Untch, Ingo Bauerfeind, Michael Patrick Lux, Markus Bühner, Juliane Manitz, Veronika Fensterer, Karin Münzel, Two different sides of ‘chemobrain’: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study, Psycho-Oncology, 2010, 19, 12
  25. 25
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2009, 18, 12